
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-07-29IMTX3Power of Attorney for Immatics N.V.MEDIUM
This filing details a Power of Attorney granted by James Nelson Pepin, reporting owner, to Ephraim HofsΓ€Γ, Lorenzo Gerardi, and Mona Rinn. The attorneys-in-fact are authorized to maintain SEC EDGAR system credentials, execute and file Forms 3, 4, and 5 on behalf of Mr. Pepin in his capacity as a reporting person for Im...
Small CapBiotechnology
2026-07-29BLNK3Dennis C. Schemm Form 3 Filing for Blink Charging Co. Director Position
This is a Form 3 filing indicating Dennis C. Schemm's appointment as a director of Blink Charging Co. (BLNK). The filing shows Schemm as a director (isDirector: 1) but not an officer or 10% owner. Notably, the "noSecuritiesOwned" field is set to 1, suggesting that at the time of filing, Schemm did not own any securitie...
Micro CapEngineering & Construction
2026-07-29HUM3Insider Filing for Humana Inc.
This filing reports a change in beneficial ownership for Paul John Smith, a director at Humana Inc. (HUM). The report indicates that following a transaction, Mr. Smith now owns 0 shares of Humana Common stock. This is an initial filing (Form 3) detailing ownership changes for insiders....
Mega CapHealthcare Plans
2026-07-29ILMN3Form 3 Filing for Michael C. Sullivan, Chief Commercial Officer of Illumina, Inc.
This filing reports initial ownership of securities by Michael C. Sullivan, Chief Commercial Officer of Illumina, Inc. (ILMN). The report, dated July 29, 2026, pertains to the period ending July 20, 2026. Mr. Sullivan, through Robert Maynes, has reported no securities owned as of the reporting date. The filing is a For...
Mega CapDiagnostics & Research
2026-07-29DT3Dynatrace Director Chandrasekhar Thota Grants Power of Attorney for SEC Filings
This SEC Form 3 filing includes a Limited Power of Attorney granted by Chandrasekhar Thota, a director of Dynatrace, Inc. (NYSE: DT), to Nicole Fitzpatrick and Marc Gold. The power of attorney authorizes these individuals to execute various SEC filings on Thota's behalf, including Forms 3, 4, 5, Form 144, Schedules 13D...
Large CapSoftware - Application
2026-07-28CNC3Power of Attorney for Section 16 Reporting ObligationsMEDIUM
This filing details a Power of Attorney granted by Paul J. Diaz, a director of Centene Corporation (CNC), to Christopher A. Koster and others. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5, along with any necessary amendments, with the SEC on behalf of Mr. Diaz. This authorization is for re...
Mega CapHealthcare Plans
Sponsored
2026-07-28CENTENE CORP3Power of Attorney for Section 16 Reporting ObligationsDuplicateMEDIUM
This filing details a Power of Attorney granted by Paul J. Diaz, a director of Centene Corporation (CNC), to Christopher A. Koster and others. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5, along with any necessary amendments, with the SEC on behalf of Mr. Diaz. This authorization is for re...
Mega CapHealthcare Plans
2026-07-28SNSE3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28GETY3Power of Attorney Filing for Thomas B. WalperMEDIUM
This filing documents a Power of Attorney granted by Thomas B. Walper to Kjelti Kellough, Jennifer Leyden, and Heather Wilde of Getty Images Holdings, Inc. The attorneys-in-fact are authorized to act on Mr. Walper's behalf regarding U.S. Securities and Exchange Commission (SEC) filings. This includes actions necessary ...
Micro CapInternet Content & Information
2026-07-28HAE3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial statement of beneficial ownership of securities for Martin D. Madaus, a director at HAEMONETICS CORP. The report, dated July 24, 2026, indicates that Mr. Madaus has no securities owned. The filing was signed by Thomas V. Powers, attorney-in-fact for Dr. Madaus, on July 28, 2026....
Mid CapMedical Devices
2026-07-28JBDI3JBDI Holdings Ltd - Neo Chin Heng Form 3 Filing for 3,947,910 Ordinary Shares
This SEC Form 3 filing reports the initial beneficial ownership of Neo Chin Heng, a shareholder of JBDI Holdings Ltd. The filing discloses ownership of 3,947,910 ordinary shares with a par value of US$0.001 each. Neo Chin Heng holds these shares indirectly through E U Holdings, where he owns 50% of the shares along wit...
Nano CapSpecialty Retail
2026-07-28JBDI3Form 3 Filing for JBDI Holdings Ltd by Shareholder Ng Eng Guan
This is a Form 3 initial statement of beneficial ownership filing for JBDI Holdings Ltd (ticker: JBDI) by shareholder Ng Eng Guan. The filing reports ownership of 3,947,910 ordinary shares with a par value of US$0.001 each. The ownership is indirect, with Ng Eng Guan and Neo Chun Heng each owning 50% of the shares of E...
Nano CapSpecialty Retail
Sponsored
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology
2026-07-28HAEMONETICS CORP3Initial Statement of Beneficial Ownership of SecuritiesDuplicate
This filing reports the initial statement of beneficial ownership of securities for Martin D. Madaus, a director at HAEMONETICS CORP. The report, dated July 24, 2026, indicates that Mr. Madaus has no securities owned. The filing was signed by Thomas V. Powers, attorney-in-fact for Dr. Madaus, on July 28, 2026....
Mid CapMedical Devices
2026-07-28JBDI Holdings Ltd3JBDI Holdings Ltd - Neo Chin Heng Form 3 Filing for 3,947,910 Ordinary SharesDuplicate
This SEC Form 3 filing reports the initial beneficial ownership of Neo Chin Heng, a shareholder of JBDI Holdings Ltd. The filing discloses ownership of 3,947,910 ordinary shares with a par value of US$0.001 each. Neo Chin Heng holds these shares indirectly through E U Holdings, where he owns 50% of the shares along wit...
Nano CapSpecialty Retail
Sponsored
2026-07-28JBDI Holdings Ltd3Form 3 Filing for JBDI Holdings Ltd by Shareholder Ng Eng GuanDuplicate
This is a Form 3 initial statement of beneficial ownership filing for JBDI Holdings Ltd (ticker: JBDI) by shareholder Ng Eng Guan. The filing reports ownership of 3,947,910 ordinary shares with a par value of US$0.001 each. The ownership is indirect, with Ng Eng Guan and Neo Chun Heng each owning 50% of the shares of E...
Nano CapSpecialty Retail
2026-07-28OTLY3Power of Attorney for Lifen XuMEDIUM
This filing indicates that Lifen Xu, a director of Oatly Group AB, has executed a Power of Attorney. This document authorizes specific individuals, including Pontus Mattsson and Timothy SjΓΆvall, to act as her legal representatives. They are empowered to execute and file necessary forms, such as Forms 3, 4, and 5, in ac...
Small CapPackaged Foods
2026-07-28Faeth Therapeutics, Inc.3Vinod Khosla & Khosla Ventures Entities File Form 3 for Faeth TherapeuticsDuplicateMEDIUM
This Form 3 filing discloses initial beneficial ownership of Faeth Therapeutics, Inc. (FTH) by Vinod Khosla and related Khosla Ventures entities. The filing reports ownership of 1,643,349 shares of common stock held by Khosla Ventures VI, L.P. and 988,883 shares held by Khosla Ventures Seed D, L.P., totaling 2,632,232 ...
Nano CapBiotechnology